Importantly, an ethyl ester prodrug 8 exhibits cellular target engagement and effectively blocksthe proliferation of colon cancer cell lines, further validating pharmacologicalinhibition of KMT9 as a promising strategy for cancer therapy. The gene discussed is HEMK2; the disease is colonic neoplasm.